Abnormal collagen deposition in synovia after collagen type V immunization in rabbits

Histology and Histopathology

Volumn 23, Issue 3, 2008, Pages 263-269

  Ogido, Luciana Tsuzuki Ichicawa ^a   Teodoro, Walcy Rosolia ^a   Velosa, Ana Paula Pereira ^a   de Oliveira, Cristiane Carla ^a   Parra, Edwin Roger ^a   Capelozzi, Vera Luiza ^a   Yoshinari, Natalino Hajime ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Collagen type V; Experimental model; Fibrosis; Scleroderma; Synovia

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 5; MONOCLONAL ANTIBODY;

ANIMAL; ARTICLE; DISEASE MODEL; EXTRACELLULAR MATRIX; FEMALE; IMMUNIZATION; IMMUNOLOGY; METABOLISM; PATHOLOGY; RABBIT; SYNOVIUM; SYSTEMIC SCLEROSIS;

ANIMALS; ANTIBODIES, MONOCLONAL; COLLAGEN TYPE I; COLLAGEN TYPE III; COLLAGEN TYPE V; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; FEMALE; IMMUNIZATION; RABBITS; SCLERODERMA, SYSTEMIC; SYNOVIAL MEMBRANE;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 84863980835     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Adachi E. and Hayashi T. (1986). In vitro formation of hybrid fibrils of type V collagen and Type I collagen: Limited growth of type I collagen into thick fibrils by type V collagen. Connect. Tissue Res. 14, 257-266
2. Adachi E., Hopkinson I. and Hayashi T. (1997). Basement-membrane stromal relationships: interactions between collagen fibrils and the lamina densa. Int. Rev. Cytol. 173, 73-156.
3. Andrikopoulos K., Liu X., Keene D.R., Jaenisch R. and Ramirez F. (1995). Targeted mutation in the col5a2 gene reveals a regulatory role for type V collagen during matrix assembly. Nat. Genet. 9, 31-36.
4. Bezerra M.C., Teodoro W.R., Oliveira C.C., Velosa A.P.P., Ogido L.T.I., Gauditano G., Parra E.R., Capelozzi, V.L. and Yoshinari N.H. (2006). Scleroderma-like remodeling induced by type V collagen. Arch. Dermatol. Res. 298, 51-57.
5. Birk D.E. (2001). Type V collagen: heterotypic type I/V collagen interactions in the regulation of fibril assembly. Micron 32, 223-237.
6. Burrows N.P., Nicholls A.C., Yates J.R.W., Gatward G., Sarathachandha P., Richard A. and Pope F.M. (1996). The gene encoding collagen I(V) (col 5A1) is linked to mixed Ehlers-Danlos syndrome type I/II. J. Invest. Dermatol. 106, 1273-1276.
7. Clark S.H. (2005) Animal models in SSc. Rheumatol. Rep. 7, 150-155.
8. Haque M.A., Mizobuchi T., Yasufuku K., Fujisawa T., Brutkiewicz R.R., Zheng Y., Woods K., Smith G.N., Cummings O.W., Heidler K.M., Blum J.S. and Wilkes D.S. (2002). Evidence for immune responses to a self-antigen in lung transplantations: Role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection. J. Immunol. 169, 1542-1549.
9. Hay E.D. (1991). Matrix assembly. In:Cell biology of extracelular matrix, Hay E.D. (eds). 20th ed. Plenum. New York. pp 221-249.
10. Laemmll U.K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
11. Leroy E.C. (1996). Systemic sclerosis (scleroderma). In: Cecil Textbook of Medicine. Bennett J.C. and Plum F. (eds). 20th Ed. WB Saunders Company. Philadelphia. PA. pp 1483-1489.
12. Linsenmayer T.F., Fitch J.M. and Birk D.E. (1990). Heterotypic collagen fibrils and stabilizing collagens: Controlling elements in corneal morphogenesis. Ann. NY Acad. Sci. 580, 143-160.
13. Mckown K.M., Carbone L.D., Bustillo J., Seyer J.M., Kang A.H. and Postlethwaite A.E. (2000). Induction of immune tolerance to human type I collagen in patients with systemic sclerosis by oral administration of bovine type I collagen. Arthritis. Rheum. 43, 1054-1061.
14. Michalickova K., Susic M., Willing M.C., Wenstrup R.I. and Cole W.G. (1998). Mutations of the alpha 2 (V) chain of type V collagen impair matrix assembly and produce Ehlers-Danlos syndrome type I. Hum. Mol. Genet. 7, 249-255.
15. Niyibizi C., Fietzek P.P. and Rest V.M. (1984). Human placenta type V collagens. Evidence for the existence of an α1(V), α2(V),α3(V). Col. Mol. 259, 14170-14174.
16. Rogers C. and Edelman E.R. (1995). Endovascular stent design dictates experimental restenosis and trombosis. Circulation 91, 2995-3001.
17. Saito E., Fujimoto M., Hasegawa M., Komura K., Hamaguchi Y., Kaburagi Y., Nagaoka T., Takehara K., Tedder T.F. and Saito S. (2002). CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse. J. Clin. Invest. 109, 1453-1462.
18. Sgonc R. (1999). The vascular perspectives of systemic sclerosis: of chickens, mice and men. Int. Arch. Allergy Immunol. 120, 169-176.
19. Shirotani M., Yui Y. and Kawai C. (1993). Restenosis after coronary angioplasty: pathogenesis of neointimal thickening initiated by endothelial loss. Endothelium 1, 5-22.
20. SPSS Statistical software (2002). Version 10.0. SPSS Inc, Chicago
21. Sykes B.Ç. and Bailey A.I. (1971). Molecular weight heterogeneity of the chain sub-units of collagen. Biochem. Biophys. Res. Com. 43, 340-345.
22. Teodoro W.R., Miron B.G., Ogido L.T., Velosa A.P., Abatepaulo F., Capelozzi V.L. and Yoshinari N.H. (2003). Synovial remodeling process induced by type V collagen immunization in rabbits. Pathol. Res. Pract. 199, 605-612.
23. Teodoro W.R., Velosa A.P., Witzel S.S., Garippo A.L., Farhat C., Parra E.R., Sonohara S., Capelozzi V.L. and Yoshinari N.H. (2004). Architectural remodeling in lungs of rabbits induced by type V collagen immunization: a preliminary morphologic model to study diffuse connective tissue diseases. Pathol. Res. Pract. 200, 681-691.
24. Underwood P.A., Bean P.A. and Whitelock J.M. (1998). Inhibition of endothelial cell adhesion and proliferation by extra cellular matrix from vascular smooth muscle cells: role of type V collage. Atherosclerosis 141, 141-152.
25. Wilkes D.S. (2003). The role of autoimmunity in the pathogenesis of lung allograft rejection. Arch. Immunol. Ther. Exp. (Warsz) 51, 227-230.
26. Yamamoto T. and Nisshioka K. (2005). Cellular and molecular mechanisms of bleomycin-induced murine SSc: current update and future perspective. Exp. Dermatol. 14, 81-95
27. Yasufuku K., Heidler K.M., O'donnell P.W., Smith Jr G.N., Cummings O.W., Foresman B.H., Fujisawa T. and Wilkes D.S. (2001). Oral tolerance induction by type V collagen downregulates lung allograft rejection. Am. J. Respir. Cell. Mol. Biol. 25, 26-34.
28. Yasufuku K., Heidler K.M., Woods K.A., Smith G.N.J., Cummings O.W., Fujisawa T. and Wilkes D.S. (2002). Prevention of bronchiolitis obliterans in rat lung allografts by type V collagen-induced oral tolerance. Transplation 73, 500-505.
29. Yoshinari N.H., Teodoro W.R., Ogido L.T.I., Velosa A.P.P., Prizon C.P., Miron B., Bissoli J.C.C., Cuentas E.R.P. and Capelozzi V.L. (2002). Modelo experimental de doenças difusas do tecido conjuntivo (DDTC) induzido por colágeno do tipo V. Ver. Bras. Reumatol. 42, 295-305.
30. Ziats N.P. and Anderson J.M. (1993). Human vascular endothelial cell attachment and growth inhibition by type V collagen. J. Vasc. Surg. 17, 710-718.
31. Zhang Y. and Gilliam A.C. (2002). Animal models for SSc: an update. Curr. Rheumatol. Rep. 4, 150-162.